Prevention and management of infections associated with burns in the combat casualty

Journal of Trauma - Injury, Infection and Critical Care

Volumn 64, Issue SUPPL. 3, 2008, Pages

  D'Avignon, Laurie C ^a   Saffle, Jeffrey R ^b   Chung, Kevin K ^c   Cancio, Leopoldo C ^c  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Burns; Combat; Infection; Trauma

Indexed keywords

ANTIBIOTIC AGENT; BURNAZINE; CEPHALOSPORIN DERIVATIVE; ECHINOCANDIN; MAFENIDE; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; SILVER NITRATE; SULFADIAZINE SILVER; THERMAZINE; VORICONAZOLE;

ANTIMICROBIAL THERAPY; BACTERIUM CULTURE; BATTLE INJURY; BURN INFECTION; CANDIDA; CONFERENCE PAPER; DEBRIDEMENT; EVIDENCE BASED PRACTICE; EXCISION; INFECTION CONTROL; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; TISSUE GRAFT; WOUND CARE; WOUND DRESSING; BURN; EVIDENCE BASED MEDICINE; HUMAN; MILITARY MEDICINE; REVIEW; WAR; WOUND INFECTION;

BURNS; EVIDENCE-BASED MEDICINE; HUMANS; MILITARY MEDICINE; WAR; WOUND INFECTION;

EID: 43149084614     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318163c3e4     Document Type: Conference Paper

References (112)

1. Chung CK, Blackbourne LH, Wolf SE, et al. Evolution of burn resuscitation in Operation Iraqi Freedom. J Burn Care Res. 2006;27:606-611.
2. Kauvar DS, Wolf SE, Wade CE, et al. Burns sustained in combat explosions in Operations Iraqi and Enduring Freedom. Burns. 2006;32:853-857.
3. Mayhew ER. The Reconstruction of Warriors: Archibald McIndoe, the Royal Air Force and the Guinea Pig Club. London: Greenhill Books; 2004.
4. Aub JC, Beecher HK, Cannon B, et al. Management of the Cocoanut Grove Burns at the Massachusetts General Hospital. Philadelphia, PA: J.B. Lippincott; 1943.
5. Dalton ML. Champ Lyons: an incomplete life. Ann Surg. 2003;237:694-703.
6. Pruitt BA Jr. Combat casualty care and surgical progress. Ann Surg. 2006;243:715-729.
7. Allen BD, Whitson TC, Henjyoji EY. Treatment of 1,963 burned patients at 106th General Hospital, Yokohama, Japan. J Trauma. 1970;10:386-392.
8. Anonymous. Annual Research Progress Reports. Ft. Sam Houston, TX: U.S. Army Institute of Surgical Research; 1967-1972.
9. Cancio LC, Barillo DJ, Kopchinski BJ, et al. Burn support for Operation Iraqi Freedom and related operations, 2003 to 2004. J Burn Care Res. 2005;26:151-161.
10. Lindberg RB, Moncrief JA, Switzer WE, et al. The successful control of burn wound sepsis. J Trauma. 1965;5:601-616.
11. Heimbach DM. Early burn excision and grafting. Surg Clin North Am. 1987;67:93-107.
12. Sorensen B, Frisker NP, Steensen JP, Kalaja E. Acute excision or exposure treatment? Final results of a three-year randomized controlled clinical trial. Scand J Plast Reconstr Surg. 1984;18:87-93.
13. Herndon DN, Barrow RE, Rutan RL, et al. A comparison of conservative versus early excision: therapies in severely burned patients. Ann Surg. 1989;209:547-553.
14. Ong YS, Samuel M, Song C. Meta-analysis of early excision of burns. Burns. 2006;32:145-150.
15. Wolf S, Kauvar DS, Wade CE, et al. Comparison between civilian burns and combat burns from Operation Iraqi Freedom and operation enduring freedom. Ann Surg. 2006;243:786-795.
16. Mayhall GC. The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003;37:543-550.
17. Erol S, Altoparak U, Akcay M, et al. Changes of microbial flora and wound colonization in burned patients. Burns. 2004;30:357-361.
18. Barret JP, Herndron DN. Effects of burn wound excision on bacterial colonization and invasion. Plast Reconstr Surg. 2003;111:744-750.
19. Revathi G, Puri J, Jain BK. Bacteriology of burns. Burns. 1998;24:347-349.
20. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg. 1998;22:135-145.
21. Sherertz RJ, Sullivan ML. An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients' mattresses. J Infect Dis. 1985;151:252-258.
22. Bayat AH, Shaaban H, Dodgson A, Dunn KW. Implications for burns unit design following outbreak of multi-resistant Acinetobacter infection in ICU and burns unit. Burns. 2003;29:303-306.
23. Mayhall CG, Lamb VA, Gayle WE, Haynes BW. Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak. J Infect Dis. 1979;139:166-171.
24. Church D, Elasayed S, Reid O, et al. Burn wound infections. Clin Microbiol Rev. 2006;19:403-434.
25. Agnihotri N, Gupra V, Joshi RM. Aerobic bacterial isolates from burn wound infections and their antibiograms-a five-year study. Burns. 2004;30:241-243.
26. Albrecht MA, Griffith ME, Murray CK, et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll of Surg. 2006;203:546-550.
27. Marshall JH, Bromberg BE, Adrizzo JR, et al. Fatal tetanus complicating a small partial thickness burn. J Trauma. 1972;12:91-93.
28. Burdge JJ, Rea F, Ayers L. Noncandidal, fungal infections of the burn wound. J Burn Care Res. 1988;9:599-601.
29. Schofield CM, Murray CK, Horvath EE, et al. Correlation of culture with histopathology in fungal burn wound colonization and infection. Burns. 2007;33:341-346.
30. Horvath EE, Murray CK, Vaughan, et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg. 2007;245:978-985.
31. Pruitt BA Jr. The diagnosis and treatment of infection in the burn patient. Burns. 1984;11:79-83.
32. Pruitt BA Jr, McManus AT. The changing epidemiology of infection in burn patients. World J Surg. 1992;16:57-60.
33. Becker WK, Cioffi WG, McManus AT, et al. Fungal burn wound infection. Arch Surg. 1991;126:44-48.
34. Grieshop TJ, Yarbrough D, Farrar WE. Case report: phaeohyphomycosis due to Curvularia lunata involving skin and subcutaneous tissue after an explosion at a chemical plant. Am J Med Sci. 1993;305:387-389.
35. Sheridan RL, Schulz JT, Weber JM, et al. Cutaneous herpetic infections complicating burns. Burns. 2000;26:621-624.
36. McGill SN, Cartotto RC. Herpes simplex virus infection in a paediatric burn patient: case report and review. Burns. 2000;26:194-199.
37. Brown TP, Cancio LC, McManus AT, Mason AD. Survival benefit conferred by topical antimicrobial preparations in burn patients: a historical perspective. J Trauma. 2004;56:863-866.
38. Pruitt BA Jr, O'Neill JA Jr, Moncrief JA, Lindberg RB. Successful control of burn-wound sepsis. JAMA. 1968;203:1054-1056.
39. Purdue GF, Hunt JL. Chondritis of the burned ear: a preventable complication. Am J Surg. 1986;152:257-259.
40. Wolf SE, Herndon DN. Burns. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery, 17th ed. Philadelphia: Elsevier; 2004.
41. Gerding RL, Emerman CL, Effron D, et al. Outpatient management of partial-thickness burns: Biobrane vs. 1% silver sulfadiazine. Ann Emer Med. 1990;19:121-124.
42. Barret JP, Dziewulski P, Ramzy PI, et al. Biobrane versus 1% silver sulfadiazine in second degree pediatric burns. Plast Reconstr Surg. 2000;105:62-65.
43. Moyer CA, Brentano L, Gravens DL, et al. Treatment of large burns with 0.5% silver nitrate solution. Arch Surg. 1965;90:812-814.
44. Harrison HN, Bales H, Jacoby F. The behavior of mafenide acetate as a basis for its clinical use. Arch Surg. 1971;103:449-453.
45. Thompson PD, Taddonio TE, Tait MJ, Prasad JK. Susceptibility of Pseudomonas and Staphylococcus wound isolates to topical antimicrobial agents: a 10-year review and clinical evaluation. Burns. 1989;15:190-192.
46. Fox CL Jr. Silver sulfadiazine - a new topical therapy for Pseudomonas in burns. Arch Surg. 1968;96:184-188.
47. Cancio LC, Howard PA, McMannus AT, et al. Burn infections. In: Holzheimer RG, Mannick JA, eds. Surgical Treatment-Evidence Based and Problem Oriented. Bern-Weun-New York: W. Zuckschwerdt Verlag Munchen; 2001:671-683.
48. White MG, Asch MJ. Acid-base effects of topical mafenide acetate in the burned patient. N Engl J Med. 1971;284:1281-1286.
49. Kauvar DS, Acheson E, Reeder J, et al. Comparison of battlefield expedient topical antimicrobial agents for the prevention of burn wound sepsis in a rat model. J Burn Care Rehab. 2006;26:357-361.
50. Stanford W, Rappole BW, Fox CL Jr. Clinical experience with silver sulfadiazine, a new topical agent for control of Pseudomonas infections in burns. J Trauma. 1969;9:377-388.
51. Fox CL JR, Modak SM. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother. 1974;5:582-588.
52. Heggers J, Linares HA, Edgar P, et al. Treatment of infections in burns. In: Hendron, David ed. Total Burn Care. 2nd ed. Philadelphia, PA: W.B. Saunders; 1996.
53. Chu CS, McManus AT, Pruitt BA Jr, Mason AD Jr. Therapeutic effects of silver nylon dressings with weak current on Pseudomonas aeruginosa-infected burn wounds. J Trauma. 1988;28:1488-1492.
54. Tredget EE, Shankowsky HA, Groeneveld A, Rurrell R. A matchedpair, randomized study evaluating the efficacy and safety of Acticoat silver coated dressing for the treatment of burn wounds. Burn Care Res. 1998;19:531-537.
55. Thompson P, Hendron DN, Abston S, Rutan R. Effects of early excision on patients with major thermal injury. J Trauma. 1989;27:205-207.
56. Durtschi MB, Orgain C, Counts GW, et al. A prospective study of prophylactic penicillin in acutely burned hospitalized patients. J Trauma. 1982;22:11-14.
57. Ip M, Lui SL, Poon VK, et al. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol. 2006;55:59-63.
58. Dunn K, Edwards-Jones V. The role of Acticoat™ with nanocrystalline silver in the management of burns. Burns. 2004;30:S1-S9.
59. Peters DA, Verchere C. Healing at home: comparing cohorts of children with medium-sized burns treated as outpatients with inhospital applied acticoat to those children treated as inpatients with silver sulfadiazine. J Burn Care Res. 2006;27:198-201.
60. Klein MB, Heimbach D, Gibran N. Management of the burn wound. In: Fink MP, Jurkovich GJ, Kaiser LR, Pearce WH, Pemberton JH, Soper NJ, eds. ACS Surgery: Principles & Practice. New York, NY: WebMD Inc; 2004.
61. Stout L, Jezior J, Melton L, et al. Wartime burn care in Iraq: 28th Combat Support Hospital, 2003. Mil Med. 2007;172:1148-1153.
62. Lilly HA, Lowbury EJ. Antibiotic resistance of Staphylococcus aureus in a burns unit after stopping routine prophylaxis with erythromycin. J Antimicrob Chemother. 1978;4:545-550.
63. Ugbururo AO, Atoyebi OA, Oyeneyin JO, Sowemimo GOA. An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital. Burns. 2004;30:43-48.
64. Rashid A, Brown AP, Khan K. On the use of prophylactic antibiotics in prevention of toxic shock syndrome. Burns. 2005;31:981-985.
65. Piel P, Scarnati S, Goldfarb W, et al. Antibiotic prophylaxis in patients undergoing burn wound excision. J Burn Care Res. 1985;6:422-425.
66. Sasaki TM, Welch GW, Herndon DN, et al. Burn wound manipulation-induced bacteremia. J Trauma. 1979;19:46-48.
67. Mozingo DW, McManus AT, Kim SH, et al. Incidence of bacteremia after burn wound manipulation in the early postburn period. J Trauma. 1997;42:1006-1010; discussion 10-11.
68. Steer JA, Papini RP, Wilson AP, et al. Randomized placebo-controlled trial of teicoplanin in the antibiotic prophylaxis of infection following manipulation of burn wounds. Br J Surg. 1997;84:848-853.
69. Alexander JW, MacMillan BG, Law EJ, et al. Prophylactic antibiotics as an adjunct for skin grafting in clean reconstructive surgery following burn injury. J Trauma. 1982;22:687-690.
70. Papini RP, Wilson AP, Steer JA, et al. Wound management in burn centers in the United Kingdom. Br J Surg. 1995;82:505-509.
71. Dacso CC, Luterman A, Curreri PW. Systemic antibiotic treatment in burned patients. Surg Clin North Am. 1987;67:57-68.
72. Murray CK, Hoffmaster RM, Schmit DR, et al. Evaluation of elevated temperature, white blood cell count, and neutrophil percentage as predictors of bloodstream infection in burn ICU patients. Arch Surg. 2007;142:639-642.
73. Hodle AE, Richter KP, Thompson RM. Infection control practices in US burn units. J Burn Care Res. 2006;27:142-151.
74. Weber J, McManus AT. Infection control in burn patients. Burns. 2004;30:A16-A24.
75. Howard P, Cancio L, McManus AT, et al. What's new in burn-associated infections. Curr Surg. 1999;56:397-405.
76. Fleming RY, Zeigler ST, Walton MA, et al. Influence of burn size on the incidence of contamination of burn wounds by fecal organisms. J Burn Care Res. 1991;12:510-515.
77. Dodd D, Stutman HR. Current issues in burn wound infections. Adv Pediatr Infect Dis. 1991;6:137-162.
78. Taddonio TE, Thomson PD, Smith DJ Jr, et al. A survey of wound monitoring and topical antimicrobial therapy practices in the treatment of burn injury. J Burn Care Res. 1990;11:423-427.
79. Kagan RJ, Matsuda T, Hanumadass M, et al. Serious wound infections in burned patients. Surgery. 1985;98:640-647.
80. Simor AE, Lee M, Veracombe M, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epi. 2002;23:261-267.
81. Pearman JW. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control. J Hosp Infect. 2006;63:14-26.
82. Douglas MW, Mulholland K, Denyer V, et al. Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit-an infection control study. Burns. 2001;27:131-135.
83. Edgar P, Mlcak R, Desai M, et al. Containment of a multiresistant Serratia marcescens outbreak. Burns. 1997;23:15-18.
84. McManus AT, Mason AD Jr, McManus WF, Pruitt BA Jr. A decade of reduced gram-negative infections and mortality associated with improved isolation of burned patients. Arch Surg. 1994;15:143-146.
85. Murray CK, Roop SA, Hospenthal DR, et al. Bacteriology of war wounds at time of injury. Mil Med. 2006;171:826-829.
86. Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings: Recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epi. 2002;23(suppl):S3-S40.
87. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epi. 2002;23:759-769.
88. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epi. 2003;24:362-386.
89. Siegel JD, Rhinehart E, Jackson M, et al. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Infect Control Hosp Epi. 2007;2007:1-219.
90. Gallagher J, Williams-Bouyer N, Villarreal C, et al. Treatment of infection in burns. In: Herndon DN, ed. Total Burn Care. Philadelphia: Elsevier, Inc; 2007:136-176.
91. Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51:540-544.
92. Sjoberg T, Mzezewa S, Jonsson K, et al. Comparison of surface swab cultures and quantitative tissue biopsy cultures to predict sepsis in burn patients: a prospective study. J Burn Care Res. 2003;24:365-370.
93. Danilla S, Andrades P, Gomez ME, et al. Concordance between qualitative and quantitative cultures in burned patients. Analysis of 2886 cultures. Burns. 2005;31:967-971.
94. Tahlan RN, Keswani RK, Saini S, et al. Correlation of quantitative burn wound biopsy culture and surface swab culture to burn wound sepsis. Burns Incl Therm Inj. 1984;10:217-224.
95. Steer JA, Papini RP, Wilson AP, et al. Quantitative microbiology in the management of burn patients. I. Correlation between quantitative and qualitative burn wound biopsy culture and surface alginate swab culture. Burns. 1996;22:173-176.
96. Woolfrey BF, Fox JM, Quall CO. An evaluation of burn wound quantitative microbiology. I. Quantitative eschar cultures. Am J Clin Pathol. 1981;75:532-537.
97. Freshwater MF, Su CT. Potential pitfalls of quantitative burn wound biopsy cultures. Ann Plast Surg. 1980;4:216-218.
98. McManus AT, Kim SH, McManus WF, et al. Comparison of quantitative microbiology and histopathology in divided burn-wound biopsy specimens. Arch Surg. 1987;122:74-76.
99. Muangman P, Deubner H, Honari S, et al. Correlation of clinical outcome of Integra application with microbiologic and pathological biopsies. J Trauma. 2006;61:1212-1217.
100. Greenleaf G, Cooper ML, Hansbrough JF. Microbial contamination in allografted wound beds in patients with burns. J Burn Care Res. 1991;12:442-445.
101. Steer JA, Papini RP, Wilson AP, et al. Quantitative microbiology in the management of burn patients. II. Relationship between bacterial counts obtained by burn wound biopsy culture and surface alginate swab culture, with clinical outcome following burn surgery and change of dressings. Burns. 1996;22:177-181.
102. Pirnay JP, De Vos D, Duinslaeger L, et al. Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid 'real-time' polymerase chain reaction. Crit Care. 2000;4:255-261.
103. Chowers MY, Gottesman B, Paul M, et al. Persistent bacteremia in the absence of defined intravascular foci: clinical significance and risk factors. Eur J Clin Microbiol Infect Dis. 2003;22:592-596.
104. Marvin JA, Heck EL, Loebl EC, et al. Usefulness of blood cultures in confirming septic complications in burn patients: evaluation of a new culture method. J Trauma. 1975;15:657-662.
105. Keen A, Knoblock L, Edelman L, et al. Effective limitation of blood culture use in the burn unit. J Burn Care Res. 2002;23:183-189.
106. Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents. 2000;15:83-90.
107. Ekenna O, Sherertz RJ, Bingham H. Natural history of bloodstream infections in a burn patient population: the importance of candidemia. Am J Infect Control. 1993;21:189-195.
108. McManus WF, Mason RD, Pruitt BA. Subeschar antibiotic infusion in the treatment of burn wound infection. J Trauma. 1980;20:1021-1023.
109. McManus WF, Goodwin CW, Pruitt BA. Burn wound infection. J Trauma. 1981;21:753-756.
110. McManus WF, Goodwin CW, Pruitt BA. Subeschar treatment of burn wound infection. Arch Surg. 1983;118:291-294.
111. Baxter CR, Curreri PW, Marvin JA. The control of burn wound sepsis by the use of quantitative bacteriologic studies and subeschar clysis with antibiotics. Surg Clin N Am. 1973;53:1509-1518.
112. Holder IA, Durkee P, Supp AP, Boyce ST. Assessment of a silver coated barrier dressing for potential use with skin grafts on excised burns. Burns. 2003;29:445-448.